1-Morpholino-2-((2-(pyrrolidin-1-yl)quinolin-8-yl)oxy)ethan-1-one

ID: ALA4745312

PubChem CID: 162648533

Max Phase: Preclinical

Molecular Formula: C19H23N3O3

Molecular Weight: 341.41

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(COc1cccc2ccc(N3CCCC3)nc12)N1CCOCC1

Standard InChI:  InChI=1S/C19H23N3O3/c23-18(22-10-12-24-13-11-22)14-25-16-5-3-4-15-6-7-17(20-19(15)16)21-8-1-2-9-21/h3-7H,1-2,8-14H2

Standard InChI Key:  SYFSZAQMHXUNGM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   23.6559   -1.6839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6547   -2.5034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3628   -2.9124    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3610   -1.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0696   -1.6803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0703   -2.4993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7789   -2.9064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4871   -2.4955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4824   -1.6734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7733   -1.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9471   -2.9087    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2008   -2.5758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6535   -3.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0616   -3.8907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8610   -3.7213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7806   -3.7235    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.4891   -4.1307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1960   -3.7206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9045   -4.1277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1943   -2.9034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.9039   -4.9498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6084   -5.3569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3177   -4.9503    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.3179   -4.1322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6089   -3.7206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  2 11  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 19 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4745312

    ---

Associated Targets(Human)

HEp-2 (3859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Respiratory syncytial virus (3434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 341.41Molecular Weight (Monoisotopic): 341.1739AlogP: 2.07#Rotatable Bonds: 4
Polar Surface Area: 54.90Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.01CX LogP: 1.98CX LogD: 1.98
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.85Np Likeness Score: -1.94

References

1. Wang M,Zhang G,Zhao J,Cheng N,Wang Y,Fu Y,Zheng Y,Wang J,Zhu M,Cen S,He J,Wang Y.  (2021)  Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents.,  214  [PMID:33571829] [10.1016/j.ejmech.2021.113208]

Source